Benefit of medication reviews by renal pharmacists in the setting of a computerized physician order entry system with clinical decision support
Order entry
DOI:
10.1111/jcpt.13697
Publication Date:
2022-07-23T01:54:20Z
AUTHORS (7)
ABSTRACT
A 'renal pharmacist consultant service' (RPCS) reviewing patients' charts with renal impairment (RI) for drug-related problems (DRP) can foster patient safety. However, the benefit of this service in new setting a computerized physician order entry (CPOE)-system clinical decision support (CDS)-system is unknown. The aim our study was to evaluate general need an RPCS on wards CPOE-CDS-system already use and its effectiveness prescription changes ensure in-hospital safety.Over period 3 months (02-04/2021), elective orthopaedic trauma patients eGFRabsolute /CrCl <60 ml/min at German University Hospital received medication review by all entered into CPOE-system (Meona®) treating physicians. Written consultations explaining identified DRP recommending interventions solve them, example, dose or drug adaptation, were shared physicians directly chart tab Meona®. In complex cases, additionally discussed via phone. evaluated retrospectively.During 53 working days, 712 (30.5%) 2331 screened included eGFRnon-indexed pharmacist-led performed presented (Meona®). 79 (11.1%) patients, one more detected (median 1 (1-3) per patient) written recommendations concerning 106 1090 (9.7%) drugs total, 104 identified, mostly caused 'dosage too high' (n = 55, 52.9%), regime wrong' 13, 12.5%), 'contraindication' 9, 8.7%). Acceptance rate 74.0% 77/104). nine cases (8.7%), despite specific recommendations, no adjustment made because lack alternatives. 11 (10.6%) remained unchanged unknown reasons seven (6.7%) result due discharge.In prescribing CPOE-CDS-system, that provides advice adaption, reviews still RI. forwarding electronic medical record increased appropriate and, thus, may further improve
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....